MedTrace Logo

BrainAgeMS - a Comparative Study of Brain Aging in Healthy and Patients With Multiple Sclerosis

NCT06221631 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-02-13

No results posted yet for this study

Summary

The purpose of this study is to investigate new quantitative MRI-sequences for assessment of age-specific data for the prediction of brain aging.

Conditions

Sponsors & Collaborators

  • Schweizerische Multiple Sklerose Gesellschaft

    collaborator OTHER

  • University of Bern

    collaborator OTHER

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Robert Hoepner, PD Dr.med. · Head of the MS outpatient clinic

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-27
Primary Completion
2028-03-31
Completion
2028-10-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06221631 on ClinicalTrials.gov